Liabilities / Assets
6th percentile
Higher debt load relative to assets than 6% of similar nonprofits.
Precomputed percentiles for this filing year versus similar nonprofits in the same peer cohort.
Liabilities / Assets
6th percentile
Higher debt load relative to assets than 6% of similar nonprofits.
Liabilities / Revenue
17th percentile
Higher debt load relative to revenue than 17% of similar nonprofits.
Net Margin
71st percentile
Higher net margin than 71% of similar nonprofits.
Top Officer Pay
Score unavailable
This filing does not contain officer compensation rows.
Asset Growth
11th percentile
Faster asset growth than 11% of similar nonprofits.
Revenue Growth
6th percentile
Faster revenue growth than 6% of similar nonprofits.
Assets
Down$117,669,582
Down $7,427,023 (-5.9%) from 2014
Net Assets
Down$116,903,872
Down $7,405,997 (-6.0%) from 2014
Liabilities
Down$765,710
Down $21,026 (-2.7%) from 2014
Revenue
Down$5,496,777
Down $3,143,356 (-36%) from 2014
Expenses
Up$4,818,883
Up $131,917 (+2.8%) from 2014
Net Income
Down$677,894
Down $3,275,273 (-83%) from 2014
This 2015 filing currently has summary financial data only. Detailed schedules, leadership, and program rows are not available for this filing yet.
As a supporting organization to the Clayton Foundation for Research (Clayton), the organizations primary mission is to fund medical research for the purpose of discovering the cause, prevention and cure of diseases for the benefit of mankind. The secondary mission is to transfer the resulting medical research discoveries from the laboratory to the use of the general public by patenting and licensing such technology for development into drugs or other products for the use and benefit of mankind through Claytons other supporting entities.
No mirrored PDF or thumbnail assets are attached yet.
Displayed year
2015 • Form 990Summary only. Only limited summary data is available for this year.